Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers

• Published in: PloS one Vol. 13; no. 12; p. e0209515
• Main Authors: Gebrehiwot, Abrha G, Melka, Daniel Seifu, Kassaye, Yimenashu Mamo, Rehan, Ibrahim F, Rangappa, Shobith, Hinou, Hiroshi, Kamiyama, Toshiya, Nishimura, Shin-Ichiro
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 28.12.2018; Public Library of Science (PLoS)
• Subjects: Abundance; Acids; Age; Atherosclerosis; Biochemistry; Biological markers; Biology and Life Sciences; Biomarkers; Biomarkers, Tumor; Case-Control Studies; Cell adhesion & migration; Chromatography, High Pressure Liquid; Computational Biology; Cultural differences; Ethnicity; Fluorescence; Genetic aspects; Genetic variation; Glycan; Glycoproteins; Glycoproteins - blood; Glycosylation; Hepatocellular carcinoma; High-performance liquid chromatography; Humans; Immunoglobulins; Life sciences; Lipids; Liquid chromatography; Liver cancer; Mannose; Medicine; Medicine and Health Sciences; Metabolism; Minority & ethnic groups; N-glycans; Neoplasms - blood; Neoplasms - diagnosis; Patients; People and Places; Physical Sciences; Physiological aspects; Polysaccharides; Population; Prostate cancer; Proteins; Proteomics; Proteomics - methods; Quantitative analysis; R&D; Reproducibility of Results; Research & development; Research and Analysis Methods; Signal transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stem cells; Studies; Variation; Japan; Ethiopia; Addis Ababa Ethiopia
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0209515

Most glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to investigate the inter-ethnic serum N-glycan variation among US origin control, Japanese, Indian, and Ethiopian healthy volunteers. Human serum from 54 healthy subjects of various ethnicity and 11 Japanese hepatocellular carcinoma (HCC) patients were included in the study. We employed a comprehensive glycoblotting-assisted MALDI-TOF/MS-based quantitative analysis of serum N-glycome and fluorescence HPLC-based quantification of sialic acid species. Data representing serum N-glycan or sialic acid levels were compared among the ethnic groups using SPSS software. Total of 51 N-glycans released from whole serum glycoproteins could be reproducibly quantified within which 33 glycoforms were detected in all ethnicities. The remaining N-glycans were detected weakly but exclusively either in the Ethiopians (13 glycans) or in all the other ethnic groups (5 glycans). Highest abundance (p < 0.001) of high mannose, core-fucosylated, hyperbranched/hypersialylated N-glycans was demonstrated in Ethiopians. In contrast, only one glycan (m/z 2118) significantly differed among all ethnicities being highest in Indians and lowest in Ethiopians. Glycan abundance trend in Ethiopians was generally close to that of Japanese HCC patients. Glycotyping analysis further revealed ethnic-based disparities mainly in the branched and sialylated structures. Surprisingly, some of the glycoforms greatly elevated in the Ethiopian subjects have been identified as serum biomarkers of various cancers. Sialic acid level was significantly increased primarily in Ethiopians, compared to the other ethnicities. The study revealed ethnic-specific differences in healthy human serum N-glycome with highest abundance of most glycoforms in the Ethiopian ethnicity. The results strongly emphasized the need to consider ethnicity matching for accurate glyco-biomarker identification. Further large-scale study employing various ethnic compositions is needed to verify the current result.